Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function.

Area of Science:

• Biochemistry
• Genetics
• Cell Biology

Background:

• Neutral lipid storage diseases (NLSDM and NLSDI) are rare autosomal recessive disorders.
• Mutations in PNPLA2 and ABHD5/CGI58 genes impair adipose triglyceride lipase (ATGL) and α-β hydrolase domain 5 (ABHD5) function.
• Lipid droplets (LDs) are vital organelles for lipid metabolism and energy homeostasis, and their dysfunction causes NLSD.

Purpose of the Study:

• To review genetic and clinical data from NLSD patients, focusing on organ damage.
• To explore how NLSD patient cells serve as models for investigating LD structure and function.
• To enhance understanding of LDs' role in cellular physiology and disease.

Main Methods:

• Review of genetic and clinical data from patients with NLSDM and NLSDI.
• Analysis of cellular models derived from NLSD patients with impaired LD function.
• Examination of the structural and functional consequences of PNPLA2 or ABHD5/CGI58 mutations on LDs.

Main Results:

• NLSD patients exhibit muscle, skin, heart, and liver damage due to impaired LD function.
• Cells from NLSD patients exhibit partial or total knockdown of PNPLA2 or ABHD5/CGI58.
• NLSD cells provide a unique model to study LD dynamics and metabolic roles.

Conclusions:

• Understanding NLSD pathogenesis deepens our knowledge of lipid droplet biology.
• NLSD patient-derived cells are invaluable tools for dissecting LD function and dysfunction.
• Targeting LD pathways may offer therapeutic strategies for NLSD and related metabolic disorders.